Yong-Lim Kim

ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment

Philip Kam‐Tao Li, Kai Ming Chow, Yeoungjee Cho et al. · Peritoneal Dialysis International · 2022 · 648 citations

Medicine, Internal Medicine, Pharmacotherapy +13

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 215 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +13

Independent Effects of Systemic and Peritoneal Inflammation on Peritoneal Dialysis Survival

Mark Lambie, James Chess, Kieron Donovan et al. · Journal of the American Society of Nephrology · 2013 · 191 citations · Full text

Medicine, Immunology, Nephrology +17

A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival

Jongha Park, Connie M. Rhee, John J. Sim et al. · Kidney International · 2013 · 150 citations · Full text

Medicine, Nephrology, Comparative Effectiveness Research +14

Superior Patient Survival for Continuous Ambulatory Peritoneal Dialysis Patients Treated with a Peritoneal Dialysis Fluid with Neutral pH and Low Glucose Degradation Product Concentration (Balance)

Ho Yung Lee, Hyeong Cheon Park, Bo Jeung Seo et al. · Peritoneal Dialysis International · 2005 · 147 citations

Medicine, Nephrology, Dialysis +12